TBG Diagnostics' Series E Round

TBG Diagnostics raised a round of funding on June 16, 2003.

TBG Diagnostics, formerly Progen Pharma, is a globally focused biotechnology company headquarted in Brisbane with offices in San Francisco and North Carolina, USA. The company draws on considerable e…

Articles about TBG Diagnostics' Series E Round: